Does Rallies show 13F holders for TARA?

Yes. Rallies tracks hedge fund and 13F ownership data for TARA, including fund names, share counts, latest tracked quarter, and position changes when available.

Is TARA research on Rallies investment advice?

No. Rallies provides research, data, and educational context for TARA. It does not provide personalized investment advice.

TARA (Protara Therapeutics, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

Protara Therapeutics, Inc. Common Stock (TARA) is a publicly traded Healthcare sector company. As of May 21, 2026, TARA trades at $4.73 with a market cap of $258.54M and a P/E ratio of -3.52. TARA moved +9.91% today. Year to date, TARA is -11.69%; over the trailing twelve months it is +36.78%. Its 52-week range spans $1.60 to $10.48. Analyst consensus is strong buy with an average price target of $25.83. Rallies surfaces TARA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns TARA stock?

Hedge funds tracked by Rallies that own TARA include Panagora Asset. The latest tracked quarter is Dec 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Protara Therapeutics, Inc. Common Stock.

TARA Key Metrics

Key financial metrics for TARA
Metric	Value
Price	$4.73
Market Cap	$258.54M
P/E Ratio	-3.52
EPS	$-1.34
Dividend Yield	0.00%
52-Week High	$10.48
52-Week Low	$1.60
Volume	750
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-57.44M
Gross Margin	0.00%

Top Hedge Funds Holding TARA

Panagora Asset holds 43.80K shares of TARA, changed +0.00% as of Dec 31, 2025.

Latest TARA News

Protara to Unveil 12-Month Interim Data from 31-Patient Phase 2 Bladder Cancer Trial — Apr 27, 2026
Protara Posts 68% Six-Month NMIBC Response, Plans 100-Patient Trial Expansion — Mar 2, 2026
Protara Highlights Strong Phase 2 TARA-002 Response Rates in NMIBC at ASCO GU — Feb 25, 2026
Protara’s TARA-002 Achieves 68% Six-Month NMIBC Response Rate — Feb 24, 2026

Recent TARA Insider Trades

Zummo Jacqueline sold 1.13K (~$6.12K) on Apr 8, 2026.
Zummo Jacqueline sold 22.60K (~$118.87K) on Apr 1, 2026.
Levy Richard S bought 20.00K (~$63.80K) on May 14, 2025.

TARA Analyst Consensus

7 analysts cover TARA: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $25.83.

Common questions about TARA

Who owns TARA stock?: Hedge funds tracked by Rallies that own TARA include Panagora Asset. The latest tracked quarter is Dec 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Protara Therapeutics, Inc. Common Stock.
Does Rallies show 13F holders for TARA?: Yes. Rallies tracks hedge fund and 13F ownership data for TARA, including fund names, share counts, latest tracked quarter, and position changes when available.
Is TARA research on Rallies investment advice?: No. Rallies provides research, data, and educational context for TARA. It does not provide personalized investment advice.